Moderate Dementia
10
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
SHARE Adaptation Intervention for African-American Families
Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD
Clinical Utility and Safety of Human Umbilical Cord Mesenchymal Stem Cell Secretome in Moderate Neurocognitive Impairment (Dementia)
The Effects of a Park Visit Program on Individuals With Dementia and Their Caregivers
Effects of the Buddy-Up Dyadic Physical Activity Program on Health Outcomes of Care Dyads of Dementia: A Pilot Study
iCST Web-application for People With Dementia
Can Virtual Reality Reduce Depression and Agitation in Older Adults With Moderate to Severe Dementia?
Touchscreen Technology and Art for People With Dementia in Care Homes
Gait, cOgnitiOn & Decline (GOOD)